Epaned, Vasotec (enalapril) is a small molecule pharmaceutical. Enalapril was first approved as Epaned on 1985-12-24. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme. Vasotec's patents are valid until 2036-03-25 (FDA).
|Trade Name||Epaned, Vasotec|
|Indication||bartter syndrome, diabetic nephropathies, edema, heart failure, left ventricular dysfunction, malignant hypertension, rheumatoid arthritis|
|Drug Class||Narcotic agonists/antagonists (normorphine type); antihypertensives (ACE inhibitors)|